These success, together with a preceding report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 help the strategy of focusing on ACKR3 as a unique method to modulate the opioid method, which could open new therapeutic avenues for opioid-linked disorders. Importantly, these receptors had been https://carolinec284arj3.blog2news.com/profile